To read this content please select one of the options below:

Research funding cuts will curb recovery in Brazil

Wednesday, July 7, 2021


Financial constraints on public research and development (R&D) have been worsening over years. The suspension of tax-free imports in late May adds further uncertainty to ongoing research, with many imports focusing on the development of new vaccines and drugs against COVID-19.


  • Federal public universities, already experiencing large budget cuts, are likely to suspend some R&D and investments.
  • Scientific development and research will not be a priority for the current government.
  • Bolsonaro’s criticism of universities may prompt interference in their activities.
  • Lack of public financing for R&D raises additional questions over Brazil’s recovery.

Related articles

Expert Briefings logo